Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Pharma major Dr Reddy’s Laboratories has completed Phase II clinical trials for the Russian Covid vaccine candidate, Sputnik V, in India.
A spokesperson for the Hyderabad-based company told BusinessLine on Thursday that the trials were completed with both doses given to all subjects.
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, has collaborated with Dr Reddy’s to conduct clinical trials and distribute the vaccine in India.
Dr Reddy’s will begin Phase III trials shortly and complete it in March.
The completion of Sputnik trials is being eagerly awaited by all stakeholders as already two vaccines; Covishield of Serum Institute and Covaxin of Bharat Biotech, have been given emergency use approval by the drug regulator.
The Russian authorities claim that Sputnik V had reduced by 92 per cent the possibility of those inoculated being clinically diagnosed with symptomatic Covid-19. In the meanwhile, Sputnik is all set for manufacturing in India.
When asked if Dr Reddy’s has already been getting the vaccine stocks, the spokesperson said: “Our approach is a combination of importing from Russia plus manufacturing in India.”
Russia has inked pacts with four large manufacturers and India will produce 30 crore doses or more of the vaccine for RDIF in 2021.
The RDIF and Hyderabad-based Hetero, through its biologics arm Hetero Biopharma, had also inked a pact to produce more than 10 core doses of Sputnik V annually in India.
Hetero said it will start production of Sputnik in early 2021.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
With initial public offerings galore, we give you a cheat sheet to score some good grades
Biggest risk in selling funds in a rising scenario is exiting early and missing out on further gains
Go for a standard vector-borne diseases policy if you don’t have a regular health plan
No credit risk is an attraction, but note the nuances
With the public looking beyond mainstream media for reports from the ground, independent digital platforms are ...
While Supreme Court has cleared the way for women seeking longer tenures and senior roles in the Indian Army, ...
Mughal Gardens in the Capital open to visitors — albeit with Covid-19 protocol — for the annual Udyanotsav
Salty, buttery, cheese coated or with maple syrup and bacon — popcorn is lending its adaptable self to gourmet ...
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor